Bausch Health Companies Inc. has announced new shareholder agreements with major investor groups, including the Icahn Group, the Paulson Group, and the Kavanagh Group, as of May 20, 2025. These agreements dictate that if any group engages in a "Specified Action," such as initiating a proxy contest against the company, they must resign from the boards of both Bausch Health and Bausch + Lomb. Furthermore, the Icahn Group has agreed to waive certain rights from previous agreements. As long as no specified actions are taken, the company will support group nominees for board elections and appointments to new board committees, provided no conflicts of interest arise. Full details of these agreements are available in the attached exhibits.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。